175
Views
7
CrossRef citations to date
0
Altmetric
Original Article

NBHA Reduces Acrolein-Induced Changes in ARPE-19 Cells: Possible Involvement of TGFβ

, , &
Pages 370-378 | Received 12 Jul 2010, Accepted 14 Dec 2010, Published online: 10 Feb 2011

REFERENCES

  • Fine SL, Berger JW, Maguire MG, et al. Age-related macular degeneration. N Engl J Med. 2000;342:483–492.
  • Kuksa V, Imanishi Y, Batten M, et al. Retinoid cycle in the vertebrate retina: Experimental approaches and mechanisms of isomerization. Vision Res. 2003;43:2959–2981.
  • Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: Comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res. 1997;49:268–280.
  • Kevany BM, Palczewski K. Phagocytosis of retinal rod and cone photoreceptors. Physiology (Bethesda). 2010;25:8–15.
  • Kopitz J, Holz FG, Kaemmerer E, et al. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie. 2004;86:825–831.
  • Chen H, Liu B, Lukas TJ, et al. The aged retinal pigment epithelium/choroid: A potential substratum for the pathogenesis of age-related macular degeneration. PLoS One 2008;3:e2339.
  • Radu RA, Hu J, Yuan Q, et al. Complement System Dysregulation and Oxidative Stress in the abca4-/- Mice. In: ARVO, Ft. Lauderdale, FL, 2010.
  • Zhou J, Kim SR, Westlund BS, et al. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci. 2009;50:1392–1399.
  • Nagineni CN, Samuel W, Nagineni S, et al. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen-activated protein kinases. J Cell Physiol. 2003;197:453–462.
  • Muether PS, Hermann MM, Koch K, et al. Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity. Graefes Arch Clin Exp Ophthalmol. 2010.
  • Frippiat C, Chen QM, Zdanov S, et al. Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem. 2001;276:2531–2537.
  • Frippiat C, Dewelle J, Remacle J, et al. Signal transduction in H2O2-induced senescence-like phenotype in human diploid fibroblasts. Free Radic Biol Med. 2002;33:1334–1346.
  • Yu AL, Fuchshofer R, Kook D, et al. Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Invest Ophthalmol Vis Sci. 2009;50:926–935.
  • Unda R, Vidro-Kotchan E. Unpublished results. 2003.
  • Vogt RR, Unda R, Yeh LC, et al. Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. J Cell Biochem. 2006;98:1196–1202.
  • Bian ZM, Elner SG, Elner VM. Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res. 2007;84:812–822.
  • Khan JC, Thurlby DA, Shahid H, et al. Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol. 2006;90:75–80.
  • Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration: A review of association. Eye. 2005;19:935–944.
  • Lykkesfeldt J, Christen S, Wallock LM, et al. Ascorbate is depleted by smoking and repleted by moderate supplementation: A study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr. 2000;71:530–536.
  • O’Neill CA, Halliwell B, van der Vliet A, et al. Aldehyde-induced protein modifications in human plasma: Protection by glutathione and dihydrolipoic acid. J Lab Clin Med. 1994;124:359–370.
  • Cross CE, O’Neill CA, Reznick AZ, et al. Cigarette smoke oxidation of human plasma constituents. Ann N Y Acad Sci. 1993;686:72–89; discussion 89–90.
  • Bertram KM, Baglole CJ, Phipps RP, et al. Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: Implications for age-related macular degeneration. Am J Physiol Cell Physiol. 2009;297:C1200–C1210.
  • Nguyen E, Picklo MJ Sr. Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation. Biochim Biophys Acta. 2003;1637:107–112.
  • Pan J, Chung FL. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions. Chem Res Toxicol. 2002;15:367–372.
  • Bazan NG. Survival signaling in retinal pigment epithelial cells in response to oxidative stress: Significance in retinal degenerations. Adv Exp Med Biol. 2006;572:531–540.
  • Sheu SJ, Liu NC, Chen JL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther. 2010;26:231–236.
  • Voloboueva LA, Liu J, Suh JH, et al. (R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage. Invest Ophthalmol Vis Sci. 2005;46:4302–4310.
  • Jia L, Liu Z, Sun L, et al. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: Protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci. 2007;48:339–348.
  • Shen JK, Dong A, Hackett SF, et al. Oxidative damage in age-related macular degeneration. Histol Histopathol. 2007;22:1301–1308.
  • Zhou J, Cai B, Jang YP, et al. Mechanisms for the induction of HNE-, MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res. 2005;80:567–580.
  • Ayalasomayajula SP, Kompella UB. Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur J Pharmacol. 2002;449:213–220.
  • Leonarduzzi G, Scavazza A, Biasi F, et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J. 1997;11:851–857.
  • Burcham PC, Kaminskas LM, Fontaine FR, et al. Aldehyde-sequestering drugs: Tools for studying protein damage by lipid peroxidation products. Toxicology. 2002;181–182:229–236.
  • Wood PL, Khan MA, Kulow SR, et al. Neurotoxicity of reactive aldehydes: The concept of “aldehyde load” as demonstrated by neuroprotection with hydroxylamines. Brain Res. 2006;1095:190–199.
  • Yoshida M, Tomitori H, Machi Y, et al. Acrolein toxicity: Comparison with reactive oxygen species. Biochem Biophys Res Commun. 2009;378:313–318.
  • Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006;69:597–607.
  • Lange C, Thiersch M, Samardzija M, et al. The differential role of Jak/STAT signaling in retinal degeneration. Adv Exp Med Biol. 2010;664:601–607.
  • Krejsgaard T, Vetter-Kauczok CS, Woetmann A, et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia. 2006;20:1759–1766.
  • Bondi CD, Manickam N, Lee DY, et al. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol. 21:93–102.
  • Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest. 2004;84:1245–1258.
  • Pfeffer BA, Flanders KC, Guerin CJ, et al. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res. 1994;59:323–333.
  • Nagineni CN, Cherukuri KS, Kutty V, et al. Interferon-gamma differentially regulates TGF-beta1 and TGF-beta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway. J Cell Physiol. 2007;210:192–200.
  • Heimsath EG Jr, Unda R, Vidro E, et al. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res. 2006;31:1073–1080.
  • Batista CK, Brito GA, Souza ML, et al. A model of hemorrhagic cystitis induced with acrolein in mice. Braz J Med Biol Res. 2006;39:1475–1481.
  • Joshi-Barve S, Amancherla K, Patil M, et al. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: Relevance to hepatitis C. Free Radic Biol Med. 2009;47:47–54.
  • Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Res. 2007;35:7497–7504.
  • Pan J, Keffer J, Emami A, et al. Acrolein-derived DNA adduct formation in human colon cancer cells: Its role in apoptosis induction by docosahexaenoic acid. Chem Res Toxicol. 2009;22:798–806.
  • Park YS, Taniguchi N. Acrolein induces inflammatory response underlying endothelial dysfunction: A risk factor for atherosclerosis. Ann N Y Acad Sci. 2008;1126:185–189.
  • Saiki R, Nishimura K, Ishii I, et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke. 2009;40:3356–3361.
  • Sakata K, Kashiwagi K, Sharmin S, et al. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun. 2003;305:143–149.
  • Tomitori H, Usui T, Saeki N, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke. 2005;36:2609–2613.
  • Williams TI, Lynn BC, Markesbery WR, et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging. 2006;27:1094–1099.
  • Woodruff TJ, Wells EM, Holt EW, et al. Estimating risk from ambient concentrations of acrolein across the United States. Environ Health Perspect. 2007;115:410–415.
  • Kapphahn RJ, Giwa BM, Berg KM, et al. Retinal proteins modified by 4-hydroxynonenal: Identification of molecular targets. Exp Eye Res. 2006;83:165–175.
  • Kaemmerer E, Schutt F, Krohne TU, et al. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci. 2007;48:1342–1347.
  • Schutt F, Bergmann M, Holz FG, et al. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2003;44:3663–3668.
  • Liu Z, Sun L, Zhu L, et al. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem. 2007;103:2690–2700.
  • Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004;242:91–101.
  • Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 2000;55:15–35; discussion 35–36.
  • Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997;81:154–162.
  • Vidro EK, Gee S, Unda R, et al. Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr Eye Res. 2008;33:984–993.
  • Gong G, Qin Y, Huang W, et al. Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis. Chem Biol Interact. 2010;184:366–375.
  • Kwolek-Mirek M, Bednarska S, Bartosz G, et al. Acrolein toxicity involves oxidative stress caused by glutathione depletion in the yeast Saccharomyces cerevisiae. Cell Biol Toxicol. 2009;25:363–378.
  • Lee SC, Seong GJ, Kim SH, et al. Synthesized TGF-beta s in RPE regulates cellular proliferation. Korean J Ophthalmol. 1999;13:16–24.
  • Atamna H, Paler-Martinez A, Ames BN. N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem. 2000;275:6741–6748.
  • Hipkiss AR. On the anti-aging activities of aminoguanidine and N-t-butylhydroxylamine. Mech Ageing Dev. 2001;122:169–171.
  • Lee JH, Kim IS, Park JW. The use of N-t-butyl hydroxylamine for radioprotection in cultured cells and mice. Carcinogenesis. 2004;25:1435–1442.
  • Stevens JF, Maier CS. Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 2008;52:7–25.
  • Carmella SG, Chen M, Zhang Y, et al. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Effects of cigarette smoking. Chem Res Toxicol. 2007;20:986–990.
  • Chu J, Zhou CC, Lu N, et al. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J (Engl). 2008;121:2525–2533.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.